ERBB2 and cancer: Moreover, higher pCR in patients with elevated expression of ERBB2, KRT20 or ESR1 may support previous studies showing a lower cancer-specific [23] and relapse-free [22] survival of MIBC patients with high ESR1-expressing tumours.